Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 955
1.
J Allergy Clin Immunol ; 148(2): 645-651.e11, 2021 08.
Article En | MEDLINE | ID: mdl-33819511

BACKGROUND: Bronchial remodeling is a key feature of asthma that is already present in preschoolers with wheezing. Moreover, bronchial smooth muscle (BSM) remodeling at preschool age is predictive of asthma at school age. However, the mechanism responsible for BSM remodeling in preschoolers with wheezing remains totally unknown. In contrast, in adult asthma, BSM remodeling has been associated with an increase in BSM cell proliferation related to increased mitochondrial mass and biogenesis triggered by an altered calcium homeostasis. Indeed, BSM cell proliferation was decreased in vitro by the calcium channel blocker gallopamil. OBJECTIVE: Our aim was to investigate the mechanisms involved in BSM cell proliferation in preschoolers with severe wheezing, with special attention to the role of mitochondria and calcium signaling. METHODS: Bronchial tissue samples obtained from 12 preschool controls without wheezing and 10 preschoolers with severe wheezing were used to measure BSM mass and establish primary BSM cell cultures. BSM cell proliferation was assessed by manual counting and flow cytometry, ATP content was assessed by bioluminescence, mitochondrial respiration was assessed by using either the Seahorse or Oroboros technique, mitochondrial mass and biogenesis were assessed by immunoblotting, and calcium response to carbachol was assessed by confocal microscopy. The effect of gallopamil was also evaluated. RESULTS: BSM mass, cell proliferation, ATP content, mitochondrial respiration, mass and biogenesis, and calcium response were all increased in preschoolers with severe wheezing compared with in the controls. Gallopamil significantly decreased BSM mitochondrial biogenesis and mass, as well as cell proliferation. CONCLUSION: Mitochondria are key players in BSM cell proliferation in preschoolers with severe wheezing and could represent a potential target to treat BSM remodeling at an early stage of the disease.


Airway Remodeling/immunology , Bronchi/immunology , Mitochondria, Muscle/immunology , Muscle, Smooth/immunology , Respiratory Sounds/immunology , Asthma/etiology , Asthma/immunology , Asthma/pathology , Bronchi/pathology , Calcium Signaling/drug effects , Calcium Signaling/immunology , Cells, Cultured , Child, Preschool , Female , Gallopamil/pharmacology , Humans , Infant , Male , Mitochondria, Muscle/pathology , Muscle, Smooth/pathology
2.
Mol Cell Endocrinol ; 439: 444-456, 2017 01 05.
Article En | MEDLINE | ID: mdl-27717744

Testosterone (TES), other androgens and female sex steroids induce non-genomic rapid relaxing effects in airway smooth muscle (ASM). In guinea pig ASM, basal tension was relaxed by dehydroepiandrosterone (DHEA) and TES; 17ß-estradiol (E2) had a small effect. Blockers of L-type voltage dependent Ca2+ channel (L-VDCC, D-600) and store operated Ca2+ channel (SOC, 2-APB) also relaxed the basal tone. In tracheal myocytes, DHEA and TES diminished intracellular basal Ca2+ concentrations (b[Ca2+]i) as D-600+2-APB but to a higher extend. TES after D-600+2APB or Pyr3, a blocker of canonical transient receptor potential 3 (TRPC3), further decreased b[Ca2+]i rendering this response equal to TES alone. With indomethacin, the b[Ca2+]i decrease induced by the blockade of L-VDCC and TRPC3 was not changed by the addition of TES. PGE2 or forskolin addition after D600+2-APB, decreased b[Ca2+]i resembling TES response. An adenylate cyclase inhibitor followed by D-600+2-APB lowered b[Ca2+]i, TES showed no further effect. Carbachol-induced [Ca2+]i increment was reduced by TES or DHEA. 17ß-estradiol diminished KCl-induced contraction and, in tracheal myocytes, the voltage-dependent inward Ca2+ current. CONCLUSION: DHEA and TES diminish ASM tone and b[Ca2+]i by blocking L-VDCC and probably a constitutively active TRPC3, and by PGE2 synthesis. E2 lowers ASM basal tone by blocking only L-VDCC.


Calcium Channels, L-Type/metabolism , Calcium/metabolism , Gonadal Steroid Hormones/pharmacology , Intracellular Space/metabolism , Muscle, Smooth/physiology , Trachea/physiology , Animals , Boron Compounds/pharmacology , Carbachol/pharmacology , Cyclic AMP/metabolism , Dehydroepiandrosterone/pharmacology , Estradiol/pharmacology , Gallopamil/pharmacology , Guinea Pigs , Male , Muscle Cells/drug effects , Muscle Cells/metabolism , Muscle, Smooth/drug effects , Prostaglandins/metabolism , TRPC Cation Channels/metabolism , Testosterone/pharmacology
3.
Bull Exp Biol Med ; 161(4): 495-500, 2016 Aug.
Article En | MEDLINE | ID: mdl-27597056

Myeloperoxidase, heme enzyme of azurophilic granules in neutrophils, is released into the extracellular space in the inflammation foci. In neutrophils, it stimulates a dose-dependent release of lactoferrin (a protein of specific granules), lysozyme (a protein of specific and azurophilic granules), and elastase (a protein of azurophilic granules). 4-Aminobenzoic acid hydrazide, a potent inhibitor of peroxidase activity of myeloperoxidase, produced no effect on neutrophil degranulation. Using signal transduction inhibitors (genistein, methoxyverapamil, wortmannin, and NiCl2), we demonstrated that myeloperoxidase-induced degranulation of neutrophils resulted from enzyme interaction with the plasma membrane and depends on activation of tyrosine kinases, phosphatidylinositol 3-kinases (PI3K), and calcium signaling. Myeloperoxidase modified by oxidative/halogenation stress (chlorinated and monomeric forms of the enzyme) lost the potency to activate neutrophil degranulation.


Neutrophils/metabolism , Peroxidase/metabolism , 4-Aminobenzoic Acid/pharmacology , Androstadienes/pharmacology , Calcium Signaling/drug effects , Cell Degranulation/drug effects , Cells, Cultured , Gallopamil/pharmacology , Genistein/pharmacology , HL-60 Cells , Humans , Neutrophils/drug effects , Nickel/pharmacology , Oxidative Stress/drug effects , Peroxidase/antagonists & inhibitors , Phosphatidylinositol 3-Kinases/metabolism , Signal Transduction/drug effects , Wortmannin
5.
Neuroscience ; 309: 191-9, 2015 Nov 19.
Article En | MEDLINE | ID: mdl-25791230

The hippocampal CA1 region receives cortical information via two main inputs: directly via the perforant (temporoammonic) path (pp-CA1 synapse) and indirectly via the tri-synaptic pathway. Although synaptic plasticity has been reported at the pp-CA1 synapse of freely behaving animals, the mechanisms underlying this phenomenon have not been investigated. Here, we explored whether long-term potentiation (LTP) at the pp-CA1 synapse in freely behaving rats requires activation of N-methyl-d-aspartate receptors (NMDAR) and L-type voltage-gated calcium channels (VGCCs). As group II metabotropic glutamate (mGlu) receptors are densely localized on presynaptic terminals of the perforant path, and are important for certain forms of hippocampal synaptic plasticity, we also explored whether group II mGlu receptors affect LTP at the pp-CA1 synapse and/or regulate basal synaptic transmission at this synapse in vivo. In adult male rats, high-frequency stimulation (200Hz) given as 3, or 10 trains, resulted in robust LTP that lasted for at least 4h in pp-CA1 or pp-dentate gyrus (DG) synapses, respectively. Pre-treatment with the NMDAR antagonist D-(-)-2-amino-5-phosphopentanoic acid (D-AP5) partially inhibited LTP at pp-CA1, and completely prevented LTP at pp-DG synapses. Combined antagonism of NMDAR using D-AP5 and the VGCC inhibitor, (-)-methoxyverapamil hydrochloride elicited a further inhibition of the LTP response at pp-CA1 synapses. Whereas activation of group II mGlu receptors using (1R,2R)-3-((1S)-1-amino-2-hydroxy-2-oxoethyl) cyclopropane-1,2-dicarboxylic acid (DCG-IV) dose-dependently reduced basal synaptic transmission elicited by test-pulse stimulation, DCG-IV did not affect LTP in a dose that inhibited LTP at pp-DG synapses in vivo. These data indicate that LTP at the pp-CA1 synapse of freely behaving animals is dually dependent on NMDAR and VGCCs, whereby group II mGlu receptor activation affect basal synaptic tonus, but not LTP. The lower frequency-dependency of NMDA-VGCC LTP at pp-CA1 synapses compared to pp-DG synapses may comprise a mechanism to prioritize information processing at this synapse.


CA1 Region, Hippocampal/physiology , Calcium Channels, L-Type/metabolism , Long-Term Potentiation/physiology , Receptors, Metabotropic Glutamate/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism , Synapses/physiology , Animals , CA1 Region, Hippocampal/drug effects , Cyclopropanes/pharmacology , Dentate Gyrus/drug effects , Dentate Gyrus/physiology , Dose-Response Relationship, Drug , Electric Stimulation , Electrocorticography , Electrodes, Implanted , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/physiology , Gallopamil/pharmacology , Glycine/analogs & derivatives , Glycine/pharmacology , Long-Term Potentiation/drug effects , Male , Neurotransmitter Agents/pharmacology , Perforant Pathway/drug effects , Perforant Pathway/physiology , Rats, Wistar , Receptors, Metabotropic Glutamate/antagonists & inhibitors , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Synapses/drug effects , Valine/analogs & derivatives , Valine/pharmacology
6.
Am J Respir Crit Care Med ; 191(8): 876-83, 2015 Apr 15.
Article En | MEDLINE | ID: mdl-25633090

RATIONALE: Severe asthma is a major public health issue throughout the world. Increased bronchial smooth muscle (BSM) mass, a characteristic feature of airway remodeling in severe asthma, is associated with resistance to high-intensity treatment and poor prognosis. In vitro, the Ca(2+)-channel blocker gallopamil decreased the proliferation of BSM cells from patients with severe asthma. OBJECTIVES: We conducted a double-blind, randomized, placebo-controlled study to evaluate the effect of gallopamil on airway remodeling in patients with severe asthma. METHODS: Subjects received either gallopamil (n = 16) or placebo (n = 15) for 1 year and were monitored for an additional 3-month period. Airway remodeling was analyzed at baseline and after treatment phase using both fiberoptic bronchoscopy and computed tomography scan. The primary end point was the BSM area. Secondary end points included normalized BSM thickness and frequency of asthma exacerbations. MEASUREMENTS AND MAIN RESULTS: BSM area was reduced in the gallopamil group (baseline vs. end of treatment) but was unchanged in the placebo group. Between-group differences in BSM area were not significantly different in gallopamil versus placebo groups. By contrast, between-group differences in normalized BSM thickness were significantly different between the two groups. The mean number of exacerbations per month was not different during the treatment phase in gallopamil versus placebo group but was significantly lower in patients previously treated with gallopamil during the follow-up period. There were no differences between the groups with respect to overall side effects. CONCLUSIONS: Gallopamil treatment for 12 months reduces BSM remodeling and prevents the occurrence of asthma exacerbations. Clinical trial registered with www.clinicaltrials.gov (NCT 00896428).


Airway Remodeling/drug effects , Asthma/drug therapy , Calcium Channel Blockers/pharmacology , Gallopamil/pharmacology , Asthma/diagnostic imaging , Bronchography/methods , Bronchoscopy/methods , Double-Blind Method , Female , Fiber Optic Technology , Follow-Up Studies , Humans , Male , Middle Aged , Tomography, X-Ray Computed/methods , Treatment Outcome
7.
Acta Pharmacol Sin ; 31(1): 19-26, 2010 Jan.
Article En | MEDLINE | ID: mdl-19915583

AIM: To quantitatively assess the effect of lowering external Ca(2+) ([Ca(2+)](o)) on both endothelium-dependent and -independent relaxations in rabbit aorta. METHODS: Isometric contractions and relaxations of isolated aortae were recorded. When assessing the effect of reduced [Ca(2+)](o) on relaxations, the normal [Ca(2+)](o) solution was substituted with one of the reduced [Ca(2+)](o) solutions for one aorta, while a paired aorta was replenished with normal [Ca(2+)](o) solution. RESULTS: The extent of acetylcholine (ACh)-induced relaxation, which is dependent on an intact endothelium, is time-dependent, and inversely related to [Ca(2+)](o) in a range of 0.02-2 mmol/L. ACh-induced relaxations were not significantly altered by the magnitude of the precontraction induced by PGF(2alpha). Nitroprusside-induced relaxations, which are independent of the endothelium, are also attenuated by reduced [Ca(2+)](o). Relaxant responses to ACh were significantly more susceptible to reduced [Ca(2+)](o) than nitroprusside-induced relaxations. A maximally effective relaxing concentration of D600, an L-type Ca channel blocker methoxyverapamil, (10(-5) mol/L) attenuated ACh-induced relaxations, whereas nitroprusside-induced relaxations were unaffected by D600. CONCLUSION: Thus, endothelium-dependent relaxation is more dependent on [Ca(2+)](o) than endothelium-independent relaxation, and it seems likely that [Ca(2+)](o) plays an important role not only in contractile processes, but also in relaxant processes as well.


Calcium/metabolism , Nitroprusside/pharmacology , Vasodilation/drug effects , Vasodilator Agents/pharmacology , Acetylcholine/pharmacology , Animals , Aorta/drug effects , Aorta/metabolism , Calcium Channel Blockers/pharmacology , Calcium Channels, L-Type/drug effects , Calcium Channels, L-Type/metabolism , Dinoprost/pharmacology , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Female , Gallopamil/pharmacology , In Vitro Techniques , Isometric Contraction/drug effects , Male , Rabbits , Time Factors
8.
Am J Physiol Cell Physiol ; 296(4): C889-99, 2009 Apr.
Article En | MEDLINE | ID: mdl-19176761

It has been suggested that store-operated Ca(2+) entry (SOC) facilitates catecholamine secretion and synthesis in bovine adrenal medullary (AM) cells. However, there has been no experimental result clearly showing that cation channel activity is enhanced by store Ca(2+) depletion. Thus the present experiments were undertaken to address the issue of whether rat AM cells have SOC channels. Inhibition of the sarco(endo)plasmic reticulum Ca(2+) (SERCA) pump resulted in a sustained increase in intracellular Ca(2+) concentration ([Ca(2+)](i)) in rat AM cells. This increase was completely suppressed by 2 mM Ni(2+) but not by 100 muM D600. A bath application of Ni(2+), but not D600, produced an outward current at -60 mV in rat AM cells, whereas exposure to a SERCA pump inhibitor did not affect either the whole cell current level or the Ni(2+)-induced outward current. The refilling of intracellular store sites was suppressed by the addition of Ni(2+) to the perfusate. RT-PCR revealed that transcripts for transient receptor potential channels 1 (TRPC1) and 5 (TRPC5) were present in rat adrenal medullas. Immunocytochemistry showed that TRPC1 channels, which have been implicated in SOC in certain types of cells, were mainly localized in the endoplasmic reticulum (ER) and not in the plasma membrane, and that STIM1, a Ca(2+) sensor in the ER, was not expressed in rat AM cells. On the basis of these results, we conclude that rat AM cells lack the SOC mechanism.


Adrenal Medulla/metabolism , Calcium Channels/metabolism , Calcium Signaling , Calcium/metabolism , Adrenal Medulla/drug effects , Animals , Calcium Channel Blockers/pharmacology , Calcium Channels/drug effects , Calcium Channels/genetics , Calcium Signaling/drug effects , Catecholamines/metabolism , Cell Membrane/metabolism , Electric Stimulation , Endoplasmic Reticulum/metabolism , Enzyme Inhibitors/pharmacology , Gallopamil/pharmacology , Indoles/pharmacology , Male , Membrane Glycoproteins/metabolism , Membrane Potentials , Nickel/metabolism , RNA, Messenger/metabolism , Rats , Rats, Wistar , Sarcoplasmic Reticulum Calcium-Transporting ATPases/antagonists & inhibitors , Sarcoplasmic Reticulum Calcium-Transporting ATPases/metabolism , Stromal Interaction Molecule 1 , TRPC Cation Channels/metabolism , Thapsigargin/pharmacology , Time Factors
9.
Eur J Pharmacol ; 573(1-3): 39-48, 2007 Nov 14.
Article En | MEDLINE | ID: mdl-17651721

Calcium currents (I(Ca)) in inner hair cells (IHCs) are carried by the Ca(v)1.3 subtype of L-type calcium channels. They play an important role in synaptic transmission of sound-evoked mechanical stimuli. L-type calcium channels are targets of the organic blocker classes dihydropyridines, phenylalkylamines and benzothiazepines. Previously a low sensitivity of the Ca(v)1.3 subtype towards dihydropyridines has been demonstrated. Therefore, this study evaluates the effect of two phenylalkylamines (verapamil and gallopamil) and the benzothiazepine diltiazem on I(Ca) through Ca(v)1.3 channels in mouse IHCs. Whole-cell I(Ca) was measured using the patch-clamp technique in mouse IHCs aged postnatal day 3-7 with 5 mM calcium as a charge carrier. The phenylalkylamines verapamil and gallopamil and the benzothiazepine diltiazem inhibited I(Ca) in IHCs in a concentration-dependent manner. This block was largely reversible. Dose-response curves revealed IC(50) values of 199+/-19 microM for verapamil, 466+/-151 microM for gallopamil and 326+/-67 microM for diltiazem. The inhibition of peak I(Ca) by phenylalkylamines and benzothiazepines was voltage-independent. Verapamil (300 microM) enhanced current inactivation from -20 to +20 mV while diltiazem (300 microM) did so only at very depolarised potentials (+20 mV). In conclusion, the concentrations of phenylalkylamines and benzothiazepine necessary to inhibit 50% of I(Ca) in IHCs were one order larger compared to concentrations which inhibited I(Ca) through Ca(v)1.2 channels in native cells or expression systems. However, inhibitory concentrations were in the same range as those required for block of I(Ca) in turtle hair cells.


Benzazepines/pharmacology , Calcium Channels, L-Type/physiology , Hair Cells, Auditory, Inner/drug effects , Phenethylamines/pharmacology , Algorithms , Animals , Animals, Newborn , Calcium Channel Blockers/pharmacology , Calcium Signaling/drug effects , Diltiazem/pharmacology , Dose-Response Relationship, Drug , Gallopamil/pharmacology , Hair Cells, Auditory, Inner/cytology , Hair Cells, Auditory, Inner/physiology , Membrane Potentials/drug effects , Mice , Mice, Inbred Strains , Verapamil/pharmacology
10.
J Neurosci ; 27(28): 7438-46, 2007 Jul 11.
Article En | MEDLINE | ID: mdl-17626204

In hippocampus, activation of the Schaffer collaterals generates an extracellular alkaline transient both in vitro and in vivo. This pH change may provide relief of the H+ block of NMDA receptors (NMDARs) and thereby increase excitability. To test this hypothesis, we augmented extracellular buffering in mouse hippocampal slices by adding 2 microM bovine type II carbonic anhydrase to the superfusate. With addition of enzyme, the alkaline transient elicited by a 10 pulse, 100 Hz stimulus train was reduced by 33%. At a holding potential (V(H)) of -30 mV, the enzyme decreased the half-time of decay and charge transfer of EPSCs by 32 and 39%, respectively, but had no effect at a V(H) of -80 mV. In current clamp, a 10 pulse, 100 Hz stimulus train gave rise to an NMDAR-dependent afterdepolarization (ADP). Exogenous enzyme curtailed the ADP half-width and voltage integral by 20 and 25%, respectively. Similar reduction of the ADP was noted with a brief 12 Hz stimulus train. The effect persisted in the presence of GABAergic antagonists or the L-type Ca2+ channel blocker methoxyverapamil hydrochloride but was absent in the presence of the carbonic anhydrase inhibitor benzolamide or when the exogenous enzyme was heat inactivated. The effects of the enzyme in voltage and current clamp were noted in 0 Mg2+ media but were abolished when (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]-cyclohepten-5,10-imine maleate was included in the patch pipette. These results provide strong evidence that endogenous alkaline transients are sufficiently large in the vicinity of the synapse to augment NMDAR responses.


Alkalies/metabolism , Hippocampus/metabolism , Pyramidal Cells/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism , Synapses/metabolism , Action Potentials , Alkalies/antagonists & inhibitors , Animals , Benzolamide/pharmacology , Calcium Channel Blockers/pharmacology , Calcium Channels, L-Type/drug effects , Carbonic Anhydrase Inhibitors/pharmacology , Carbonic Anhydrases/pharmacology , Electric Stimulation , Electrophysiology , Excitatory Postsynaptic Potentials/drug effects , Female , GABA Antagonists/pharmacology , Gallopamil/pharmacology , Hippocampus/physiology , In Vitro Techniques , Isoenzymes/pharmacology , Male , Mice , Patch-Clamp Techniques , Pyramidal Cells/physiology
11.
Mol Nutr Food Res ; 51(4): 468-72, 2007 Apr.
Article En | MEDLINE | ID: mdl-17357983

Melanoidins obtained from L-arginine and D-glucose (MW > 3500 Da) were tested for their ability to influence the contractility of gastric smooth muscles. A study within the range 0.1-10 mg/mL revealed that at low concentrations, the melanoidins provoked concentration-dependent contraction, whereas a muscle relaxation was registered at high concentrations. The contraction was preceded by changes in the calcium membrane current as measured by single sucrose-gap method and significantly attenuated by the calcium channel blockers D-600 and nifedipine. Measurements with Ca(2+)-selective electrode showed that the melanoidins decreased the concentration of ionized Ca(2+ )in tissue bath in concentration-dependent manner. Experiments carried out in solutions with lower than normal Ca(2+) concentration and using melanoidins preliminary saturated with Ca(2+ )confirmed that the calcium chelation by melanoidins was a key contributing cause for the development of relaxant response. The results obtained showed that the melanoidins could influence the contractility of smooth muscles through at least two pathways: at low concentrations they caused depolarization and activation of L-type calcium channels, stimulated the Ca(2+ )influx, and provoked contraction, whereas at high concentrations calcium binding by melanoidins led to significant depletion of extracellular calcium ions and contributed to the relaxation process observed.


Calcium/physiology , Muscle, Smooth/drug effects , Muscle, Smooth/metabolism , Polymers/pharmacology , Animals , Arginine/pharmacology , Biological Transport/drug effects , Calcium/analysis , Calcium Channel Blockers/pharmacology , Electric Conductivity , Gallopamil/pharmacology , Glucose/pharmacology , Isotonic Solutions , Male , Muscle Contraction/drug effects , Nifedipine/pharmacology , Potassium Chloride/pharmacology , Rats , Rats, Wistar , Stomach
12.
Neuropharmacology ; 52(1): 46-54, 2007 Jan.
Article En | MEDLINE | ID: mdl-16899259

Hippocampal long-term depression (LTD) comprises a persistent reduction of synaptic strength that is typically induced by low frequency stimulation (LFS). Although LTD has been described for the dentate gyrus in vitro, this phenomenon in the dentate gyrus of the intact animal is less well understood. In the current study, we investigated the contribution of NMDA receptors, L-type voltage gated calcium channels and protein synthesis to LFS-induced LTD in the dentate gyrus of freely moving rats. Animals were implanted with electrodes to enable chronic measurement of evoked potentials from medial perforant path-dentate gyrus synapses. LTD persisted for at least 24h, and was unaffected by prior treatment with the NMDA receptor antagonists AP5 or ifenprodil, which, in contrast, prevented LTP. Neither the L-type voltage-gated calcium channel antagonist, methoxyverapamil, nor the protein translation inhibitors, anisomycin or emetine had an effect on the profile of LTD. Our results suggest that NMDA receptors and L-type voltage-gated calcium channels are not involved in the induction of LTD in the dentate gyrus in vivo. Intriguingly, persistent LTD can be established without the synthesis of new proteins, suggesting that in the dentate gyrus, alternative mechanisms exist for the sustainment of enduring LTD.


Calcium Channels, L-Type/physiology , Dentate Gyrus/physiology , Long-Term Synaptic Depression/physiology , Receptors, N-Methyl-D-Aspartate/physiology , 2-Amino-5-phosphonovalerate/pharmacology , Animals , Anisomycin/pharmacology , Calcium Channel Blockers/pharmacology , Dose-Response Relationship, Drug , Dose-Response Relationship, Radiation , Electric Stimulation/methods , Emetine/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Gallopamil/pharmacology , Long-Term Synaptic Depression/drug effects , Long-Term Synaptic Depression/radiation effects , Male , Piperidines/pharmacology , Protein Synthesis Inhibitors/pharmacology , Rats , Rats, Wistar , Time Factors , Wakefulness
13.
Life Sci ; 79(9): 905-12, 2006 Jul 24.
Article En | MEDLINE | ID: mdl-16603198

BACKGROUND: Sepsis causes diaphragmatic dysfunction, which can lead to the development of respiratory failure. We previously reported that isoproterenol, non-selective beta-adrenergic agonist, improved contractility of the diaphragm in a septic rat model. Since beta(2)-adrenoceptor agonists are widely used in the treatment of chronic respiratory disease, we investigated the effect of terbutaline, a selective beta(2)-adrenergic agonist, on contractility of the septic rat diaphragm and the contribution of intracellular Ca(2+) to the effect of terbutaline in vitro. METHODS: Forty-eight rats were divided into a sham group (in which sham laparotomy was performed) and a CLP group (in which peritonitis was induced by cecal ligation and perforation). The left hemidiaphragm was removed at 16 h after the operation. The effect of terbutaline (10(-)(6) M) on contractility of the diaphragm was assessed by twitch characteristics (twitch tension, contraction time and contraction velocity) and force-frequency relationship. In addition, to investigate the role of calcium ions in the effect of terbutaline on contractility of the diaphragm, contractility of the diaphragm was assessed after the pre-incubation of the diaphragm with methoxy-verapamil (10(-)(5) M), Ca(2+)-free Krebs-Ringer's solution buffered with 2 mM of ethylene glycol tetra-acetic acid (EGTA), and ryanodine (10(-)(6) M). RESULTS: Terbutaline significantly improved twitch characteristics and force-frequency relationship of the diaphragm in the CLP group (P<0.01). Incubation with methoxy-verapamil or calcium-free solution with EGTA did not show any changes in the inotropic effect of terbutaline in the CLP group. However, incubation with ryanodine completely abolished the inotropic effect of terbutaline in the CLP group. CONCLUSIONS: The present study demonstrated that terbutaline increased contractility of the diaphragm in the septic rats. Since this inotropic effect was abolished by ryanodine administration, calcium release from the sarcoplasmic reticulum may contribute to the terbutaline-induced improvement in dysfunction of the septic diaphragm.


Adrenergic beta-2 Receptor Agonists , Adrenergic beta-Agonists/therapeutic use , Diaphragm/physiopathology , Sepsis/drug therapy , Terbutaline/therapeutic use , Animals , Calcium/physiology , Cecum/physiology , Egtazic Acid/pharmacology , Electric Stimulation , Gallopamil/pharmacology , In Vitro Techniques , Intestinal Perforation/physiopathology , Male , Muscle Contraction/drug effects , Muscle Contraction/physiology , Rats , Rats, Wistar , Ryanodine/pharmacology , Sepsis/physiopathology , Vasodilator Agents/pharmacology
14.
Nitric Oxide ; 14(1): 39-44, 2006 Feb.
Article En | MEDLINE | ID: mdl-16256381

Glibenclamide as a second-generation compound of sulfonylurea has widely been used in the treatment of type 2 diabetes patients. It has been shown that it induces apoptosis in beta cells, which is partially mediated by Ca(2+) influx. Here, we investigated the role of nitric oxide (NO) and nitric oxide synthase (NOS) isoforms on glibenclamide-induced apoptosis in rat insulinoma cells. Our results showed that glibenclamide induces NO generation (measured as nitrite) that is accompanied with decrease of cell viability in a defined concentration of glibenclamide. The effects of glibenclamide on cell viability were partially inhibited after treatment with N(G)-nitro-L-arginine methyl ester (L-NAME), inhibitor more selective for constitutive nitric oxide synthase, and in the presence of D600--a blocker of voltage-gated L-type Ca(2+) channels inhibited Ca(2+) influx into beta cells, whereas aminoguanidine (AG), a preferential inhibitor of inducible NOS, was significantly less effective. Analysis of DNA fragmentation by electrophoresis and staining with Hoechest 33342 and propidium iodide showed that L-NAME, but not AG, prevented DNA fragmentation and decreased the number of cells with condensed and fragmented nuclei. It revealed that the effects of glibenclamide on apoptosis were partially inhibited by treatment with L-NAME. In conclusion, we have shown that NO production in glibenclamide treated cells may be involved in the induction of apoptotic cell death in pure beta cell line and it may be due to Ca(2+) dependent activation of constitutive NOS isoforms.


Apoptosis/drug effects , Glyburide/pharmacology , Hypoglycemic Agents/pharmacology , Islets of Langerhans/drug effects , Nitric Oxide/physiology , Animals , Cell Line , Enzyme Inhibitors/pharmacology , Gallopamil/pharmacology , Islets of Langerhans/cytology , Microscopy, Fluorescence , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/metabolism , Nitrites/metabolism , Rats
15.
Br J Pharmacol ; 145(4): 405-14, 2005 Jun.
Article En | MEDLINE | ID: mdl-15806115

1 2-aminoethoxydiphenyl borate (2-APB) has been widely used to examine the roles of inositol 1,4,5-trisphosphate receptors (IP3Rs) and store-operated Ca2+ entry and is an emerging modulator of cationic channels encoded by transient receptor potential (TRP) genes. 2 Using Ca2+-indicator dye and patch-clamp recording we first examined the blocking effect of 2-APB on human TRPC5 channels expressed in HEK-293 cells. 3 The concentration-response curve has an IC50 of 20 microM and slope close to 1.0, suggesting one 2-APB molecule binds per channel. The blocking effect is not shared by other Ca2+ channel blockers including methoxyverapamil, nifedipine, N-propargylnitrendipine, or berberine. 4 In whole-cell and excised membrane patch recordings, 2-APB acts from the extracellular but not intracellular face of the membrane. 5 Block of TRPC5 by 2-APB is less at positive voltages, suggesting that it enters the electric field or acts by modulating channel gating. 6 2-APB also blocks TRPC6 and TRPM3 expressed in HEK-293 cells, but not TRPM2. 7 Block of TRP channels by 2-APB may be relevant to cell proliferation because 2-APB has a greater inhibitory effect on proliferation in cells overexpressing TRPC5. 8 Our data indicate a specific and functionally important binding site on TRPC5 that enables block by 2-APB. The site is only available via an extracellular route and the block shows mild voltage-dependence.


Boron Compounds/pharmacology , Calcium Channel Blockers/pharmacology , Calcium Channels/physiology , Cation Transport Proteins/physiology , Animals , Berberine/pharmacology , Calcium Channels/genetics , Cation Transport Proteins/genetics , Cell Line , Dose-Response Relationship, Drug , Electric Stimulation , Gallopamil/pharmacology , Humans , Membrane Potentials/drug effects , Mice , Nifedipine/pharmacology , Patch-Clamp Techniques , TRPC Cation Channels , TRPC6 Cation Channel , TRPM Cation Channels , Time Factors , Transfection
16.
Life Sci ; 76(25): 2903-19, 2005 May 06.
Article En | MEDLINE | ID: mdl-15820502

Embryonic stem (ES) cells are provided as a powerful tool for developmental biology and have been shown to respond to insulin. However, little is known about the effect of insulin on [Ca2+]i regulation in the ES cells, although many cellular functions are tightly regulated by [Ca2+]i. Therefore, we examined the effect of insulin on Ca2+ uptake and its related signal pathways in the mouse ES cells. Mouse ES cells expressed alkaline phosphatase (AP), transcription factor Oct-4, and stage-specific embryonic antigen-1 (SSEA-1). Insulin increased the Ca2+ uptake in a time- and dose-dependent manner and the effect was blocked by L-type Ca2+ channel blockers, nifedifine and methoxyverapamil. Genistein or herbimycin A (tyrosine kinase inhibitors), wortmannin (PI-3K inhibitor), and staurosporine or bisindolylmaleimide I (PKC inhibitors) completely prevented insulin-induced increase of Ca2+ uptake. Wortmannin blocked insulin-induced PKC activation, but SQ 22536 (adenylate cyclase inhibitor) did not. Insulin also rapidly increased formation of inositol phosphates (IPs). We examined the involvement of MAPKs in mediating the effect of insulin on Ca2+ uptake. SB 203580 (p38 MAPK inhibitor) but not PD 98059 (p44/42 MAPKs inhibitor) blocked insulin-induced increase of Ca2+ uptake. Insulin significantly increased the phosphorylation of p38 MAPK but not p44/42 MAPKs. In addition, genistein, PKI, and bisindolylmaleimide I blocked the phosphorylation of p38 MAPK by insulin, suggesting a causal relationship. In conclusion, insulin partially stimulated Ca2+ uptake via PKC, cAMP, and p38 MAPK signaling pathways in mouse ES cells.


Calcium/metabolism , Insulin/pharmacology , Mice/metabolism , Signal Transduction/drug effects , Stem Cells/metabolism , Analysis of Variance , Androstadienes/pharmacology , Animals , Benzoquinones , Biological Transport, Active/drug effects , Blotting, Western , Calcium Channel Blockers/pharmacology , Cells, Cultured , Cyclic AMP/metabolism , DNA Primers , Dose-Response Relationship, Drug , Embryo, Mammalian/cytology , Embryo, Mammalian/metabolism , Fluorescent Antibody Technique , Gallopamil/pharmacology , Genistein/pharmacology , Indoles/pharmacology , Ion Transport/drug effects , Lactams, Macrocyclic , Maleimides/pharmacology , Nifedipine/pharmacology , Protein Kinase C/metabolism , Quinones/pharmacology , Reverse Transcriptase Polymerase Chain Reaction , Rifabutin/analogs & derivatives , Staurosporine/pharmacology , Wortmannin , p38 Mitogen-Activated Protein Kinases/metabolism
17.
Am J Physiol Heart Circ Physiol ; 289(1): H398-413, 2005 Jul.
Article En | MEDLINE | ID: mdl-15708964

We recorded transmembrane potential in whole cell recording mode from small clusters (2-4 cells) of spontaneously beating 7-day embryonic chick ventricular cells after 1-3 days in culture and investigated effects of the blockers D-600, diltiazem, almokalant, and Ba2+. Electrical activity in small clusters is very different from that in reaggregates of several hundred embryonic chick ventricular cells, e.g., TTX-sensitive fast upstrokes in reaggregates vs. TTX-insensitive slow upstrokes in small clusters (maximum upstroke velocity approximately 100 V/s vs. approximately 10 V/s). On the basis of our voltage- and current-clamp results and data from the literature, we formulated a Hodgkin-Huxley-type ionic model for the electrical activity in these small clusters. The model contains a Ca2+ current (ICa), three K+ currents (IKs, IKr, and IK1), a background current, and a seal-leak current. ICa generates the slow upstroke, whereas IKs, IKr, and IK1 contribute to repolarization. All the currents contribute to spontaneous diastolic depolarization, e.g., removal of the seal-leak current increases the interbeat interval from 392 to 535 ms. The model replicates the spontaneous activity in the clusters as well as the experimental results of application of blockers. Bifurcation analysis and simulations with the model predict that annihilation and single-pulse triggering should occur with partial block of ICa. Embryonic chick ventricular cells have been used as an experimental model to investigate various aspects of spontaneous beating of cardiac cells, e.g., mutual synchronization, regularity of beating, and spontaneous initiation and termination of reentrant rhythms; our model allows investigation of these topics through numerical simulation.


Models, Cardiovascular , Myocytes, Cardiac/physiology , Periodicity , Ventricular Function , Action Potentials/physiology , Animals , Anti-Arrhythmia Agents/pharmacology , Barium/pharmacology , Biological Clocks/physiology , Calcium Channel Blockers/pharmacology , Calcium Channels/physiology , Chick Embryo , Computer Simulation , Electric Conductivity , Gallopamil/pharmacology , Homeostasis , Ions , Myocytes, Cardiac/drug effects , Patch-Clamp Techniques , Potassium Channels/physiology , Propanolamines/pharmacology
18.
J Biol Chem ; 279(53): 55211-7, 2004 Dec 31.
Article En | MEDLINE | ID: mdl-15504730

Replacement of L-type Ca(2+) channel alpha(1) subunit residue Thr-1066 in segment IIIS5 by a tyrosine residue conserved in the corresponding positions of non-L-type Ca(2+) channels eliminates high dihydropyridine sensitivity through a steric mechanism. To determine the effects of this mutation on phenylalkylamine interaction, we exploited the availability of Ca(v)1.2DHP(-/-) mice containing the T1066Y mutation. In contrast to dihydropyridines, increased protein-dependent binding of the phenylalkylamine (-)-[(3)H]devapamil occurred to Ca(v)1.2DHP(-/-) mouse brain microsomes. This effect could be attributed to an at least 2-fold increase in affinity as determined by saturation analysis and binding inhibition experiments. The latter also revealed a higher affinity for (-)-verapamil but not for (-)-gallopamil. The mutation caused a pronounced slowing of (-)-[(3)H]devapamil dissociation, indicating a stabilization of the drug-channel complex. The increased affinity of mutant channels was also evident in functional studies after heterologous expression of wild type and T1066Y channels in Xenopus laevis oocytes. 100 mum (-)-verapamil inhibited a significantly larger fraction of Ba(2+) inward current through mutant than through WT channels. Our results provide evidence that phenylalkylamines also interact with the IIIS5 helix and that the geometry of the IIIS5 helix affects the access and/or binding of different chemical classes of Ca(2+) channel blockers to their overlapping binding domains. Mutation of Thr-1066 to a non-L-type tyrosine residue can be exploited to differentially affect phenylalkylamine and dihydropyridine binding to L-type Ca(2+) channels.


Calcium Channels, L-Type/chemistry , Calcium Channels, L-Type/genetics , Calcium Channels/chemistry , Calcium/chemistry , Carrier Proteins/genetics , Dihydropyridines/chemistry , Mutation , Steroid Isomerases/genetics , Verapamil/analogs & derivatives , Animals , Brain/metabolism , Cell Membrane/metabolism , DNA, Complementary/metabolism , Dose-Response Relationship, Drug , Electrophysiology , Gallopamil/pharmacology , Homozygote , In Situ Hybridization , Isradipine/pharmacology , Kinetics , Mice , Mice, Transgenic , Microsomes/metabolism , Models, Biological , Oocytes/metabolism , Protein Binding , Protein Structure, Tertiary , RNA, Complementary/metabolism , Recombinant Proteins/chemistry , Tyrosine/chemistry , Verapamil/pharmacology , Xenopus laevis
19.
Br J Pharmacol ; 143(3): 351-60, 2004 Oct.
Article En | MEDLINE | ID: mdl-15339859

In the presence of NMDA receptor open-channel blockers [Mg(2+); (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate (MK-801); 1-amino-3,5-dimethyladamantane (memantine)] and TTX, high concentrations (30-100 microm) of either 5-hydroxytryptamine (5-HT) or alpha-methyl-5-hydroxytryptamine (alpha-Me-5-HT) significantly potentiated NMDA-induced depolarizations of frog spinal cord motoneurones. Potentiation was blocked by LY-53,857 (10-30 microm), SB 206553 (10 microm), and SB 204741 (30 microm), but not by spiroxatrine (10 microm), WAY 100,635 (1-30 microm), ketanserin (10 microm), RS 102221 (10 microm), or RS 39604 (10-20 microm). Therefore, alpha-Me-5-HT's facilitatory effects appear to involve 5-HT(2B) receptors. These effects were G-protein dependent as they were prevented by prior treatment with guanylyl-5'-imidodiphosphate (GMP-PNP, 100 microm) and H-Arg-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-D-Trp-Met-NH(2) (GP antagonist 2A, 3-6 microm), but not by pertussis toxin (PTX, 3-6 ng ml(-1), 48 h preincubation). This potentiation was not reduced by protein kinase C inhibition with staurosporine (2.0 microm), U73122 (10 microm) or N-(2-aminoethyl)-5-isoquinolinesulfonamide HCl (H9) (77 microm) or by intracellular Ca(2+) depletion with thapsigargin (0.1 microm) (which inhibits Ca(2+)/ATPase). Exposure of the spinal cord to the L-type Ca(2+) channel blockers nifedipine (10 microm), KN-62 (5 microm) or gallopamil (100 microm) eliminated alpha-Me-5-HT's effects. The calmodulin antagonist N-(6-aminohexyl)-5-chloro-1-naphtalenesulfonamide (W7) (100 microm) diminished the potentiation. However, the calcium/calmodulin-dependent protein kinase II (CaM Kinase II) blocker KN-93 (10 microm) did not block the 5-HT enhancement of the NMDA responses. In summary, activation of 5-HT(2B) receptors by alpha-Me-5-HT facilitates NMDA-depolarizations of frog motoneurones via a G-protein, a rise in [Ca(2+)](i) from the entry of extracellular Ca(2+) through L-type Ca(2+) channels, the binding of Ca(2+) to calmodulin and a lessening of the Mg(2+) -produced open-channel block of the NMDA receptor.


1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/analogs & derivatives , Motor Neurons/physiology , Receptor, Serotonin, 5-HT2B/physiology , Receptors, N-Methyl-D-Aspartate/physiology , Serotonin/analogs & derivatives , 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/pharmacology , Animals , Calcium/metabolism , Calcium Channel Blockers/pharmacology , Calcium-Calmodulin-Dependent Protein Kinases/antagonists & inhibitors , Dizocilpine Maleate/pharmacology , Dose-Response Relationship, Drug , Drug Synergism , Enzyme Inhibitors/pharmacology , Ergolines/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , GTP-Binding Proteins/metabolism , Gallopamil/pharmacology , Guanylyl Imidodiphosphate/pharmacology , Indoles/pharmacology , Magnesium/pharmacology , Memantine/pharmacology , Membrane Potentials/drug effects , Motor Neurons/drug effects , N-Methylaspartate/pharmacology , Nifedipine/pharmacology , Protein Kinase C/antagonists & inhibitors , Protein Kinase C/metabolism , Pyridines/pharmacology , Rana pipiens , Receptors, N-Methyl-D-Aspartate/agonists , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Serotonin/pharmacology , Serotonin 5-HT2 Receptor Agonists , Serotonin 5-HT2 Receptor Antagonists , Serotonin Antagonists/pharmacology , Serotonin Receptor Agonists/pharmacology , Spinal Cord/cytology , Spinal Cord/drug effects , Spinal Cord/physiology , Staurosporine/pharmacology , Sulfonamides/pharmacology , Tetrodotoxin/pharmacology
20.
Brain Res ; 1013(2): 159-67, 2004 Jul 09.
Article En | MEDLINE | ID: mdl-15193524

We investigated the effect of L-type Ca2+ channel antagonists on the Ca2+ influx through voltage-gated Ca2+ channels in leech Retzius, Leydig, AP, AE, P, and N neurons. The efficacy of the antagonists was quantified by monitoring their effect on the increase in the intracellular free Ca2+ concentration ([Ca2+]i; measured by Fura-2) that was induced by depolarizing the cell membrane by raising the extracellular K+ concentration. This K+-induced [Ca2+]i increase was blocked by the phenylalkylamines verapamil, gallopamil, and devapamil, the benzothiazepine diltiazem, as well as by the 1,4-dihydropyridine nifedipine. The blocking effect of the three phenylalkylamines was similar, being most pronounced in P and N neurons and smaller in Leydig, Retzius, AP, and AE neurons. Contrastingly, diltiazem and nifedipine were similarly effective in the neurons investigated, whereby their efficacy was like that of the phenylalkylamines in Retzius, Leydig, AP, and AE neurons. Depending on cell type and blocking agent, the concentrations necessary to suppress the K+-induced [Ca2+]i increase by 50% were estimated to vary between 5 and 190 microM. At high concentrations, the phenylalkylamines and diltiazem by themselves caused a marked [Ca2+]i increase in Leydig, P, and N neurons, which is probably due to activation of the caffeine-sensitive ion channels present in the plasma membrane of these cells. Together with previous observations, the results indicate a distant relationship of the voltage-gated Ca2+ channels present in many if not all leech neurons to vertebrate L-type Ca2+ channels.


Calcium Channel Blockers/pharmacology , Calcium Channels, L-Type/metabolism , Leeches/physiology , Neurons/metabolism , Verapamil/analogs & derivatives , Verapamil/pharmacology , Animals , Caffeine/pharmacology , Diltiazem/pharmacology , Gallopamil/pharmacology , Membrane Potentials/drug effects , Neurons/drug effects , Nifedipine/pharmacology , Phosphodiesterase Inhibitors/pharmacology
...